Novavax COVID-19 vaccine enters second round of human trials

The biotechnology company Novavax will soon begin the second phase of human testing for its COVID-19 vaccine. The so-called phase 2b clinical trial will include a group of 2,665 healthy adults in South Africa, as well as a group of…